Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SIGUEMED

Financiado

Cerrado

The first affordable and easy to use IoT system that tracks pill intake with pri...

The first affordable and easy to use IoT system that tracks pill intake with printed circuits technology SIGUEMED is provides the first cost-effective and convenient solution to an unsolved world-wide problem of massive economic and societal impact: the non-adherence to medication of chronic poly-medicated patients. Low medical adher... ver más

31/01/2020

INFARMATE ATENCION...

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

INFARMATE ATENCION FARMACEUTICA DOMICILIARIA No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-01-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INFARMATE ATENCION FARMACEUT...
50.00K€ | Lider

Proyectos interesantes

TRILLIO

Medical Technol...

Software

71K€ Cerrado

D COACH SOLUCIÓN TIC INNOVADORA PARA EL EMPOD...

Medical Technol...

Software

390K€ Cerrado

RTI2018-096935-A-I00

Medical Technol...

Data Science

121K€ Cerrado

INSULCLOCK

Medical Technol...

Software

71K€ Cerrado

INSULCLOCK

Medical Technol...

Software

1M€ Cerrado

Chip2Foil

Electronics

Medical Technol...

5M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Política de Cookies

Términos y Condiciones de uso

Política de privacidad

Aviso Legal

Innovating.Works @Copyright . Todos los derechos reservados.

Duración del proyecto: 6 meses Fecha Inicio: 2019-07-18
Fecha Fin: 2020-01-31

Líder del proyecto

INFARMATE ATENCION FARMACEUTICA DOMICILIARIA No se ha especificado una descripción o un objeto social para esta compañía.

Sin perfil tecnológico

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto SIGUEMED is provides the first cost-effective and convenient solution to an unsolved world-wide problem of massive economic and societal impact: the non-adherence to medication of chronic poly-medicated patients. Low medical adherence represents a heavy burden for the EU28 in terms of: - Cost due to extra medical treatment that needs to be given and to additional hospitalisations: estimated at 125,000 M€/year. - Premature deaths that could be avoided with correct adherence to medication: over 200,00 citizens/year Currently there are several solutions that attempt to increase medication adherence, but none of them reaches a sufficient market penetration because they are not useful enough or do not fully meet user demands. To bridge that market gap, we have developed SIGUEMED. SIGUEMED is an IoT eHealth solution aimed at fostering and monitoring medical adherence in a disruptive way. By combining a smart personalized blister pack with printed circuits in its foil (key enabling technology), wearables connected via Bluetooth to the base dock and a SW platform, we are able to remind to the patients intake the time for the intake of pills, and to track if and when this intake has taken place. If there has been any breach in the intake, a cascade of alerts is sent to contact people (relatives, caretaker, pharmacists). Access to track records and monthly reports is also possible. SIGUEMED is especially user-friendly, even for digital immigrants. To commercialize SIGUEMED we will create a network of associated pharmacies, which will be our clients and will shape our network of authorized distributors. They will sale and provide SIGUEMED’s associate services to poly-medicated patients, which are the end-users. After five year of commercialization, we expect to have built a network of more than 10,000 pharmacies in 5 different EU countries and have reached more than 350,000 patients through them. The ROI of the project is of 3.80.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores